The Cancer in Young People in Canada (CYP-C / Cancer Chez les Jeunes au Canada program, CCJC) is a national pediatric cancer surveillance program led by C17 Council with the Public Health Agency of Canada (PHAC) and the Canadian Partnership Against Cancer (CPAC),  capturing diagnosis, treatment, and short‑term outcomes (to five years) for patients under 19 managed at Canadian pediatric centres. For additional information, please see the PHAC website. The CYP-C partners are committed to transparency as an operating principle, and terms of reference are available to stakeholders (Sept 2018).

The Cancer in Young People in Canada (CYP-C) Data Tool provides pan-Canadian surveillance data on children and youth with cancer to inform research and planning for cancer control efforts.
L'outil de données sur le Cancer chez les jeunes au Canada (CCJC) fournit des données de surveillance pancanadiennes sur les enfants et les jeunes atteints de cancer afin d'orienter la recherche et la planification des efforts de lutte contre le cancer.

                                                                   

Reports and Infographics

Clinical trial enrollment of children with cancer in Canada

Participation des enfants atteints de cancer à des essais cliniques au Canada

     

Make your impact on childhood cancer / Contribuez à la lutte contre le cancer chez les enfants

Childhood Cancer Counts in Canada / Incidence du cancer chez les enfants au Canada

                                 

 

"At-a-glance – Prevalence of childhood cancer in Canada: an analysis using 5-year, 18-year and 25-year limited-duration prevalence from the CYP-C data tool" - K McKenzie, L Xie, R Khafagy, C Ricci, V Grywacheski

The Cancer in Young People in Canada report (2017) presents in-depth diagnostic, treatment, and outcome data on children under the age of 15 years diagnosed with cancer.
Le rapport Cancer chez les jeunes au Canada (2017) présente des données exhaustives sur le diagnostic, le traitement et les issues chez des enfants de moins de 15 ans ayant reçu un diagnostic de cancer.

Contact us:

Randy Barber
C17 Research Manager, CYP-C Surveillance
Randy.Barber@c17.ca